DE

The Future Map · technological enabler · active

Nanotechnology

Maturity

4 / 5

Basis, source, vintage

Mature as an enabling layer, and the clearest evidence is that its biggest deployment is not described in its own terms.

Source: Lipid nanoparticles: Onpattro (patisiran, Alnylam), the first FDA-approved LNP-RNA drug (2018); Comirnaty (Pfizer-BioNTech) and Spikevax (Moderna) mRNA vaccines deployed at global scale on LNP delivery. Nanoscale dimensions are also the semiconductor norm (2018–2024)

What it is

Engineering at the scale of individual molecules and atoms, where material properties differ from their bulk behaviour.

What it does

It is an enabling layer rather than an application: coatings, filtration membranes, drug delivery, catalysts and semiconductor features all depend on it while rarely being described in its terms.

Common misconception

That it failed to deliver. It delivered continuously and invisibly, inside products described by their function rather than by their nanoscale engineering — which is what maturity usually looks like.

Steepens

A megatrend runs at the pace of its shallowest enabler. Marginal links are shown but never set the pace.

What would change its gradient

Shares megatrends with

In the book

Why the Future Arrives Unevenly — Ch. 9 — The Closing of the Planetary Envelope · Ch. 14 — How Hype Is Manufactured

Sources


See it in the map →

Cite this entry

Talin, B. (2026). Nanotechnology. The Future Map, dataset v0.4.0 (2026-09-07). https://futuremap.talin.digital/e/nanotechnology/

Machine view: This entry as Markdown · The whole map as JSON

Updated 2026-09-02.